Literature DB >> 29483171

Autonomic Nervous System in Pulmonary Arterial Hypertension: Time to Rest and Digest.

Anna R Hemnes1, Evan L Brittain2.   

Abstract

Entities:  

Keywords:  Editorials; pulmonary hypertension

Mesh：

Year:  2018        PMID： 29483171      PMCID： PMC5830155          DOI： 10.1161/CIRCULATIONAHA.117.032355

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  17 in total

1.  Right ventricular myocardium derives from the anterior heart field.

Authors:  Stéphane Zaffran; Robert G Kelly; Sigolène M Meilhac; Margaret E Buckingham; Nigel A Brown
Journal:  Circ Res       Date:  2004-06-24       Impact factor: 17.367

Review 2.  Comprehensive invasive and noninvasive approach to the right ventricle-pulmonary circulation unit: state of the art and clinical and research implications.

Authors:  Hunter C Champion; Evangelos D Michelakis; Paul M Hassoun
Journal:  Circulation       Date:  2009-09-15       Impact factor: 29.690

3.  Chronic pulmonary artery pressure elevation is insufficient to explain right heart failure.

Authors:  Harm J Bogaard; Ramesh Natarajan; Scott C Henderson; Carlin S Long; Donatas Kraskauskas; Lisa Smithson; Ramzi Ockaili; Joe M McCord; Norbert F Voelkel
Journal:  Circulation       Date:  2009-11-02       Impact factor: 29.690

Review 4.  2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.

Authors:  Clyde W Yancy; Mariell Jessup; Biykem Bozkurt; Javed Butler; Donald E Casey; Monica M Colvin; Mark H Drazner; Gerasimos S Filippatos; Gregg C Fonarow; Michael M Givertz; Steven M Hollenberg; JoAnn Lindenfeld; Frederick A Masoudi; Patrick E McBride; Pamela N Peterson; Lynne Warner Stevenson; Cheryl Westlake
Journal:  Circulation       Date:  2017-04-28       Impact factor: 29.690

5.  Prostanoids but not oral therapies improve right ventricular function in pulmonary arterial hypertension.

Authors:  Evan L Brittain; Meredith E Pugh; Lisa A Wheeler; Ivan M Robbins; James E Loyd; John H Newman; Eric D Austin; Anna R Hemnes
Journal:  JACC Heart Fail       Date:  2013-08       Impact factor: 12.035

Review 6.  Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology.

Authors:  Anton Vonk-Noordegraaf; François Haddad; Kelly M Chin; Paul R Forfia; Steven M Kawut; Joost Lumens; Robert Naeije; John Newman; Ronald J Oudiz; Steve Provencher; Adam Torbicki; Norbert F Voelkel; Paul M Hassoun
Journal:  J Am Coll Cardiol       Date:  2013-12-24       Impact factor: 24.094

7.  Pulmonary arterial hypertension treatment with carvedilol for heart failure: a randomized controlled trial.

Authors:  Samar Farha; Didem Saygin; Margaret M Park; Hoi I Cheong; Kewal Asosingh; Suzy Aa Comhair; Olivia R Stephens; Emir C Roach; Jacqueline Sharp; Kristin B Highland; Frank P DiFilippo; Donald R Neumann; W H Wilson Tang; Serpil C Erzurum
Journal:  JCI Insight       Date:  2017-08-17

8.  Progressive right ventricular dysfunction in patients with pulmonary arterial hypertension responding to therapy.

Authors:  Mariëlle C van de Veerdonk; Taco Kind; J Tim Marcus; Gert-Jan Mauritz; Martijn W Heymans; Harm-Jan Bogaard; Anco Boonstra; Koen M J Marques; Nico Westerhof; Anton Vonk-Noordegraaf
Journal:  J Am Coll Cardiol       Date:  2011-12-06       Impact factor: 24.094

9.  Bisoprolol delays progression towards right heart failure in experimental pulmonary hypertension.

Authors:  Frances S de Man; M Louis Handoko; Joris J M van Ballegoij; Ingrid Schalij; Sylvia J P Bogaards; Pieter E Postmus; Jolanda van der Velden; Nico Westerhof; Walter J Paulus; Anton Vonk-Noordegraaf
Journal:  Circ Heart Fail       Date:  2011-12-09       Impact factor: 8.790

10.  Increased sympathetic nerve activity in pulmonary artery hypertension.

Authors:  Sonia Velez-Roa; Agnieszka Ciarka; Boutaina Najem; Jean-Luc Vachiery; Robert Naeije; Philippe van de Borne
Journal:  Circulation       Date:  2004-08-30       Impact factor: 29.690
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.